Menu

American Retired Seniors

Just another WordPress site

Dr. Clay Siegall: Public Access Into Fighting Cancer

When it comes to the fight against cancer, there are many individuals who are doing their best to eradicate this deadly disease. Over the past decade, there have been many advancements in cancer research and Dr. Clay Siegall stands at the forefront. Dr. Siegall is the CEO and the president of Seattle Genetics. This company specializes in developing and commercializing antibody-based therapies. These therapies are some of the most innovative medications thanks to their progressive capabilities. ADCETRIS, the company’s premier medication, produces great results as it attacks cancerous cells within the body while sparing the good cells. As of today, ADCETRIS has generated over $350 million in revenue for Seattle Genetics. The company has grown so fast that its stock has nearly tripled over the past few years.

Dr. Clay Siegall is the captain of the ship, and he has many years of experience from working in the industry. With a Ph.D in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland, Dr. Siegall is very well overqualified. His passion, expertise and perseverance has revolutionized the industry from the inside out. He has worked with many of the biggest names in the business. This includes:

 

  • The National Institute of Health
  • Bristol Myers Squibb
  • The National Cancer Institute

Since its inception, Seattle Genetics has grown in size and in stature. The company is located in Bothell, Washington, and it employs over 1,000 individuals. The company has a solid foundation. It prides itself on scientific innovation, drug development and rigorous research. Dr. Siegall is showing no signs of slowing down because every life counts. Cancer hits home for Siegall as he once had to watch his father struggle with the disease until his death. The fire inside of this guy is burning hot, and he won’t stop until every person is healed.

Oncotarget; a Reliable and Credible Medical Journal

Research medical information is beneficial if made available to the public. The research information is always researched by the most learned and experienced medical practitioners and researchers. Therefore, Oncotarget has come to help researchers and medical practitioners to publish their great work on oncology and other medical-related information. Oncotarget has been publishing one issue per week, but due to demand, importance, and quality of the information, they will be publishing two issues per week.

Oncotarget; a medical journal was established in 2010, and it is peer-reviewed which is accessed openly. It publishes important information which covers many aspects of oncology. With experienced researchers like Mikhail Biagoskionny and Andrel Gudkov as the editors in chief, Oncotarget has published necessary papers and information relating to oncology. They ensure that the information is credible, well researched and helpful in the medical sector. Authors are required to provide a reference for their work in recent papers to appear in the journal and read full article.

Oncotarget has an impact factor of 5.168 which is as a result of their popularity which is attributed to their accurate, insightful and constructive research papers availed in the journal. This helps the authors to have a significant impact on the medical sector with their research. When these papers are availed online, they help describe and explain specific medical issues that affect the society. The research papers can be printed as a result of particular demand. The main aim of Oncotarget is to help enhance peoplelive comfortable lives without diseases and what Oncotarget knows.

Oncotarget’s primary goal is to avail scientific results to many people and very fast. Through insightful reviews, the impact of the research is maximized. Oncotarget eliminates the border between experts and shares distinct discoveries as soon as they happen. Oncotarget has been very transformational in helping researchers publish their work and Oncotarget’s lacrosse camp.

On top of publishing oncology research papers, Oncotarget publishes endocrinology, age-related diseases, immunology, and pathology papers. This has made more research papers available to people, and it has helped many researchers who are not in the oncology field share their discoveries. This means Oncotarget has been very pivotal in research and it will continue to avail more research information. Very soon Oncotarget will start availing neuroscience and stem cell research works and Oncotarget on Facebook.

More Visit: http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid

Eric Lefkofsky Introduces Human Genome Sequencing Technology to Treat Cancer

Cancer is one of the leading killer diseases. In the United States, 40 percent of the adults are diagnosed with cancer. The National Cancer Institute estimated that 14.5 million adults were diagnosed with cancer and the figure is expected to grow 19 million by 2024. However, the situation may be less harsh in the future if the data enabled precision medicine technology spearheaded by Eric Lefkofsky, the co-founder of Tempus and Groupon.

Since the development of electronic health records (EHR) was faced by a lot of resistant, the healthcare industry is technologically railing. When Eric Lefkofsky wife was diagnosed with cancer, he was shocked to identify the huge gaps in the health sector, especially data collection technology. Although a lot of data had been collected from patients, it remained raw data and wasn’t effective.

After realizing the huge gap, Eric came with the idea of Tempus. With a goal to transform the cancer treatment sector, Tempus developed a platform that could excellently analyze clinical and molecular data obtained from patients. Although the firm had enough muscles to develop analytical software, affordable and accessible medical and clinical data presented a major hurdle. Collecting and storing patient data was the other shortcoming.

After overcoming all the challenges, Tempus developed software that promotes human genome sequencing. Eric believes that human genes hold the secret that once revealed, cancer treatment could become easier. As more data is being collected, compared, paired and analyzed, the secrets will be unlocked. With time doctors will be able to make real time decisions and identify, which medicine responds positively.

Eric Lefkofsky

Eric Lefkofsky is a decorated entrepreneur and a philanthropist. He is the co-founder of Groupon and Tempus. The shrewd entrepreneur is also the founder of Uptake Technologies, Lightbank, InnerWorkings, Echo Global Logistics and Mediaocean. Lefkofsky graduated with a bachelor’s degree from the University of Michigan before joining The University of Michigan Law School where he graduated with JD. For more info about us: https://www.tempus.com/about-us/ click here.

In 2006, Eric Lefkofsky and his wife founded Lefkofsky Family Foundation, an organization that focuses on charitable causes. Through the foundation, Eric has been able to improve the quality of life, fight for human rights, better health care as well as supporting education and art initiatives.

Dr. Avi Weisfogel – New Jersey Dentist

Dr. Avi Weisfogel is a widely known dentist in the New Jersey area. He has been practicing since 1999 when he graduated from New York University College of Dentistry. His practice is called Old Bridge Dental Care, which is still a prominent running practice. When he isn’t busy at his office, he spends time doing research and funding education for Dental Sleep Masters. He founded Dental Sleep Masters in 2014 to help dental offices learn more about oral appliances. He has been involved in years of research related to sleep apnea, and made it his mission to help those who have been diagnosed with the condition. Dental Sleep Masters properly educates staff on how to work the oral appliances and how they benefit the patient, keeping their airways open when they sleep. Dr. Weisfogel realizes how much of a problem sleep apnea has become, and many people are walking around undiagnosed. His time, energy and efforts have been dedicated to helping those around him get better sleep and wake up feeling more refreshed. He has also been working with sleep study clinics since 2010, when he founded Healthy Heart Sleep. The company focuses on managing and establishing sleep labs that test for sleep apnea.

 

When Dr. Avi Weisfogel isn’t busy with his practice or his companies, he participates in fundraisers and organizations. He has currently started a GoFundMe campaign for an organization called Operation Smile. Operation Smile started in the 1980’s, and has been going strong ever since. They are dedicated to helping children and young adolescents with their oral deformities and issues. They have raised enough money throughout the years to have completed over 200,000 surgical procedures and have traveled to more than 100 countries to do so. The foundation was originally started by two members who worked with the youth in the Philippines. They have since been able to expand their resources and their staff. They work with medical facilities in the areas where the surgery is taking place. They have treated patients with cleft lips, cleft palates and other facial deformities. They believe in treating each patient as if they were their very own child.

 

 

Avi Weisfogel’s Research on Sleep Disorders

Avi Weisfogel is an accredited dentist who is located in Old Bridge, New Jersey. He received his dentistry degree from the New York University’s College of Dentistry. Avi also graduated from the Rutgers University with a degree in Biology and Psychology. He currently practices at the Old Bridge Dental Care, which is a medical center that he created in 1999. The facility has been offering excellent services for the past one and a half decades, and this has enabled him to be offered the Best Dentist Award.

Avi Weisfogel started conducting research on sleep disorders about ten years ago. He gained interest in the field after noticing that some of his patients suffered from the condition. Avi has been determined to develop various ideal methods for curing the problem. He is the founder of Healthy Heart Sleep, which has been working closely with doctors to establish sleep labs across the globe. Weisfogel launched Dental Sleep Master in 2014 to focus on educating dentists on how they could treat sleep disorders by using their oral appliances.

The dentist has conducted extensive research on sleep apnea and is an expert in the field. According to recent studies, the problem is related to dangerous conditions such as diabetes and heart disease. Avi has been using Dental Sleep Masters in developing cures that are ideal for the treatment of the disorder. Many people across the globe are not well informed about sleep apnea, and therefore, 90 percent of the individuals who are affected by the problem are not diagnosed. Different remedies that were established in the past were less effective. Avi hopes that Dental Sleep Master will educate many dentists on how to offer effective therapies to sleep apnea patients. The FDA has approved the company’s remedies for clinical trials.

Dr. Weisfogel is famous due to his benevolence. He is a great supporter of Operation Smile’s activities. Avi currently runs a campaign on his GoFundMe account to raise funds for the charity organization. The nonprofit foundation conducts surgeries to correct facial deformations in children and youth who come from poor background. It runs its operations globally.

How Sheryl Underwood Facilitated Her Weight Loss With Dherbs.com

 

A detox program is one of the ways of getting a clean slate before you start on a weight loss program. With the kind of lifestyle most people lead nowadays, it is easy to forget how to keep your body healthy at all times. When you have a detox program in place, you can get a head start and reap the benefits that come with it.

 

 

Dherbs.com Full Body Cleanse

 

 

Sheryl Underwood is one of the celebrities who have tried various ways of losing weight. She decided to look for a product that would facilitate her weight loss program. It was while she was doing this that she discovered the Dherbs.com Full Body Cleanse.

 

 

Starting on the full body cleanse program was as easy as integrating the recommended diet into her regimen. She decided to complement her diet with regular exercise and drinking a lot of water. She recently revealed the secret to her successful weight loss and how the products by Dherbs, Inc. helped her.

 

 

If you want to be part of a program that is all-natural and which actually works, try the Dherbs.com full body cleanse. You will not only get lighter but your body will love you for it.

In a world where majority of health complications and diseases come from the processed, highly preservative-based and high sugar content, it can feel rather daunting to attempt to detoxify your body. With the products from Dherbs.com, you can have a vegan cleansing system that eliminates all of these harmful agents from your body and start to repair the damage done by unhealthy food habits. The primary focus of the 20-day cleanse is to ingest only raw foods that are beneficial to the body and avoiding empty calorie foods.

EarthlyBodies writes that the primary objective at Dherbs.com is to return the body to nature and allowing food to be your medicine. Most of common health problems (i.e. heart disease, diabetes, malnutrition, etc.) can all be prevented with healthier food choices and practicing healthier habits, so the return to nature philosophy is based on empowering the body to rejuvenate itself to the optimal level of performance allowing for a better quality of life. The best way to go about this method is to take personal initiative and incorporate self-discipline to achieve nirvana that is perfect health.

The focal point of the products that Dherbs.com provides are mainly herbal supplements to promote the healing the process of the body and recipes of raw food meals to create a strong diversity of healthy foods to keep the palate entertained while instilling healthier eating habits. There are also products to create a calming atmosphere with accessories akin to aroma therapy and cosmetic items to lower exposures of harmful chemicals and agents that are detrimental to the body. So if improving your health is a major concern, every journey starts with a single step.

Read more from Trust Pilot:
https://www.trustpilot.com/review/www.dherbs.com

The outstanding Amenities of the Copa Star Hospital

Copa Star is one of the world-class hospitals in South America. It is based in Brazil and is recognized for the excellent medical services that it offers to its clients. The facility is one of the branches of the D’Or network, which presently manages about 22 executive hospitals in different regions of Brazil. The head of the network of hospitals is Jorge Molly. He believes that the D’Or network has managed to establish the pioneer five-star medical facility in Rio de Janeiro. The idea of having a luxurious hospital that offers top-notch treatment and accommodation is new in the region. D’Or network is devoted to increasing its services by establishing other state-of-the-art hospitals in cities such as Sao Paulo.

The primary objective of the high-end hospital is to offer medical care, hospitality, and luxury to the patients. Its doctors and nurses have adequate skills and experience that allows them to provide the best services to the clients. They also use ultramodern technology in offering treatment. Copa Star has been ensuring that it has the best staff members, and therefore, it uses exceptional methods in recruiting its employees. The relaxing environment that the hospital provides attracts patients from across the country and abroad. People who need world-class medical attention will no longer need to travel to other nations. Privacy has also been one of the main factors that the hospital considers, and therefore, celebrities can be off the spotlight when they are there. Read more at SSC Magazine about Copa Star.

The Copa Star Hospital has heavily invested in medical amenities since its primary function is to treat patients who seek its services. The comfort and hospitality are secondary infrastructures. The machinery that has been installed in the hospital includes cardiac and neurological treatment equipment. It also has 59 ICUs that are fully functional. They units have video conferencing technology that allows the isolated patients to interact with their family and friends. Copa Star’s staff is made of more than 500 professionals who have been coached to offer remarkable treatment to its patients. The nurses fully understand how to handle various problems that its clientele may face.

Copa Star’s has a modern diagnostic ward that has excellent MRI machines. Its neurosurgery division also has the best infrastructure to deal with the most complicated conditions. It includes operating rooms, advanced robots, and the best surgeons. The patients are also given iPads that allow them to control their environment and contact medical personnel.

Visit their profile page on Facebook.

Mikhail Blagosklonny/ Innovative Research Against Cancer

Mikhail Blagosklonny is a scientist that is involved in cancer research and aging. Mikhail Blagosklonny is currently a professor of oncology at the esteemed Roswell Park Cancer Institute, a position he was appointed to in 2009. Blagosklonny obtained his M.D in internal medicine from Pavlov State Medical University of St. Peterburg. He also received his PhD in experimental medicine and cardiology from the same university. During his career Blagosklonny has researched and investigated many different avenues regarding cancer and its devastating effects.

He has developed theories and approaches that can one day revolutionize cancer treatment. Mikhail Blagosklonny has a broad range of research interests, from molecular and cellular biology to clinical investigations. Some of his research is specifically inclusive of cell cycle, apoptosis, mitosis, signal transduction, oncogenes and tumor suppressors. Blagosklonny, because of his in-depth research has become a strong advocate for the use of Rapamycin a possible life extending drug in the fight against cancer and has a strong hypothesis regarding the role of TOR signaling in cancer and aging.

Rapamycin in regards to cancer seems to suppress tumors and is known to increase lifespan in mice. Targeted cancer therapies that do not target healthy cells are of special interest in his research. Before Mikhail Blagosklonny’s position at Roswell Park Cancer Institute, Blagosklonny previously held positions as Associate Professor of medicine at New York Medical College, Valhalla, NY and Senior Scientist at Ordway Research Institute, Albany, NY. Mikhail Blagosklonny has published 300 research articles including reviews and book chapters.

He is the editor of several publications including Cell cycle, and Aging both of which he was editor and chief. He was also a member of the editorial board for Cell Death and Differentiation and was associate editor of Cancer Biology and Therapy. Mikhail Blagosklonny is also the author of anti-cancer approaches also known as chemotherapeutic engineering and cell cyclotherapy. He continues to aid in the fight against cancer with his dedication to performing innovative and groundbreaking research. View his LinkedIn profile.

What You Need To Know About Oncotarget

Oncotarget is a medical journal that has open access. It has gained popularity due to its multiple peer-reviewed, insightful, punctual, and constructive approaches. Oncotarget was established in 2010. It covers research on all areas of oncology. The editors-in-chief at Oncotarget are Andrei V. Gudkov and Mikhail Blagosklonny. Andrew Schally and Carlo M. Croce serve on the journal’s editorial board and have published some papers in Oncortarget. They both won the Breakthrough Prize. Oncotarget is ranked the first position among all oncology journals. Oncotarget usually publishes papers online every week. Oncotarget allows readers to print any issue or paper in cases of special demand.

Oncotarget has recently started taking papers which are on topics more than oncology. These include cardiology, cell biology, endocrinology, metabolism, and pharmacology. Oncotarget has the most prominent scientists as its leaders, and they have been able to steer the journal to success. The main aim of Oncotarget is to avail scientific results rapidly and also make them widely available. The journal also seeks to maximize research impact through insightful review. Oncotarget also enables quick sharing of exceptional discoveries and removes the border that exists between specialties. The oncology journal also links various fields when it comes to biomedical science. Read more journals on Dove Press.

Oncotarget’s mission is to foster applications of clinical and basic science so as to fight disease. Life with no disease is Oncotarget’s ultimate goal. Oncotarget focuses on the pathological basis of every type of cancer, treatment protocols, and possible therapy targets so as to enhance cancer management in patients. Oncotarget also concentrates on the impact of new therapeutic protocols and agents and management programs for patients with adherence, quality of life, and satisfaction. Oncotarget has been able to acquire a massive fan base due to insightful and informative content. The journal encourages upcoming scientists to send their articles. They get published if they qualify.

Oncotarget has become the go-to journal for those who wish to know all issues concerning oncology. The Journal has an easy to operate website whereby readers can get to read papers and issues online. Oncotarget continues to implement its strategic plans for providing their readers with comprehensive and detailed information. Follow Oncotarget on Twitter.

InnovaCare Participates In HHS Initiative To Reform Payment Models

InnovaCare has announced its participation in the LAN’s (Learning and Action Network) mission of transitioning health care payments to alternate modes. LAN is targeting to change 30% of the United States’ health care payment methods to alternate payment modes (APMs) by end of 2016 and 50% by 2018. Being an LAN committed partner, InnovaCare Health is supporting this initiative in order to accelerate the transition of the payment modes. The company has set goals that support the reform and intends to share the progress with LAN.

Through its CEO and president, Rick Shinto, InnovaCare announced that they would participate in the data survey for their Medicaid and Medicare Advantage Plans and classify payments according to the APM Framework. Richard added that the announcement reflects InnovaCare’s deep commitment to improve the healthcare industry. Taking part in the payment modes reform enhances the firm’s mission to redefine healthcare management through provision of innovative, cost-effective and coordinated care for patients on Bloomberg. Dr. Shinto explained that through alternate payment modes, InnovaCare would strengthen patient-provider bond within its networks.

LAN was created because of the demand to align payment modes among the private, public sectors of healthcare systems in the U.S. HHS launched the initiative in March 2015, with the intent to transform the healthcare industry. The alternate payment modes are methods where patients make payments depending on the quality instead of the quantity of healthcare services received. LAN has close to 100 top-committed partners from public, private and non-profit organizations that work together to enhance the healthcare system. Penelope Kokkinides, the chief administrative officer of InnovaCare, was hopeful that working together with other LAN’s devoted partners would help the company to improve its quality of services.
About InnovaCare Health

InnovaCare is the leading provider of Medicare Advantage Plans and Medicaid. In addition, the company offers physician practice services. Through the creation of sustainable and cost-effective models that are integrated with advanced technology, the company strives to offer high quality healthcare to its clients. InnovaCare operates two main Medicare Advantage Plans in Puerto Rico; PMC Medicare Choice and MMM Healthcare. It serves close to 200,000 people through a network of over 7,500 service providers.

In addition, the firm runs two Medicaid plans in Puerto Rico’s Government Health Plan (GHP) where it offers wide benefit coverage through coordinated care modes on LinkedIn. The leadership team includes Richard Shinto, M.D. and Penelope Kokkinides. The others are Christopher Joyce, Michael Sortino, S Bjasker, Jonathan Meyers and Daniel Straus.